Foxp3+ regulatory T cells in mouse models of type 1 diabetes

Citations of this article
Mendeley users who have this article in their library.


Studies on human type 1 diabetes (T1D) are facilitated by the availability of animal models such as nonobese diabetic (NOD) mice that spontaneously develop autoimmune diabetes, as well as a variety of genetically engineered mouse models with reduced genetic and pathogenic complexity, as compared to the spontaneous NOD model. In recent years, increasing evidence has implicated CD4+CD25+ regulatory T (Treg) cells expressing the transcription factor Foxp3 in both the breakdown of self-tolerance and the restoration of immune homeostasis in T1D. In this paper, we provide an overview of currently available mouse models to study the role of Foxp3+ Treg cells in the control of destructive β cell autoimmunity, including a novel NOD model that allows specific and temporally controlled deletion of Foxp3 + Treg cells. © 2013 Cathleen Petzold et al.




Petzold, C., Riewaldt, J., Watts, D., Sparwasser, T., Schallenberg, S., & Kretschmer, K. (2013). Foxp3+ regulatory T cells in mouse models of type 1 diabetes. Journal of Diabetes Research.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free